Cargando…

Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation

OBJECTIVES: To develop a nanoparticle-based MRI protocol based on transrectal administration of intestine-absorbable nanoparticle contrast agents to evaluate ulcerative colitis (UC). METHODS: Solid lipid nanoparticles (SLNs) were synthesized by loading gadolinium diethylenetriaminepentaacetic acid (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xue, Luo, Jingfeng, Lan, Pengxun, Guo, Xiuyu, Zhao, Xin, Wang, Xiaoyan, Zhou, Fei, Wang, Qiangfeng, Yuan, Hong, Sun, Jihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213572/
https://www.ncbi.nlm.nih.gov/pubmed/33409796
http://dx.doi.org/10.1007/s00330-020-07609-8
_version_ 1783709876816445440
author Dong, Xue
Luo, Jingfeng
Lan, Pengxun
Guo, Xiuyu
Zhao, Xin
Wang, Xiaoyan
Zhou, Fei
Wang, Qiangfeng
Yuan, Hong
Sun, Jihong
author_facet Dong, Xue
Luo, Jingfeng
Lan, Pengxun
Guo, Xiuyu
Zhao, Xin
Wang, Xiaoyan
Zhou, Fei
Wang, Qiangfeng
Yuan, Hong
Sun, Jihong
author_sort Dong, Xue
collection PubMed
description OBJECTIVES: To develop a nanoparticle-based MRI protocol based on transrectal administration of intestine-absorbable nanoparticle contrast agents to evaluate ulcerative colitis (UC). METHODS: Solid lipid nanoparticles (SLNs) were synthesized by loading gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) and octadecylamine-fluorescein isothiocyanate to produce Gd-FITC-SLNs as T1 contrast agents. Twenty mice with acute UC were divided into four groups: enema with Gd-FITC-SLNs, intravenous injection of Gd-FITC-SLNs, enema with Gd-DTPA, and intravenous injection of Gd-DTPA. Five mice with chronic UC and five mice without UC underwent enema with Gd-FITC-SLNs. Axial T1- and T2-weighted MR images were obtained before and 20, 40, 60, 80,100, and 120 min after enema or intravenous injection of the contrast agent. The signal-to-noise ratios (SNRs) of the colorectal wall were measured in both groups. The MRI findings were correlated with subsequent histological confirmation. RESULTS: At 20 min after enema with Gd-FITC-SLNs, MRI showed the following contrast enhancement pattern: acute UC > normal intestinal wall > chronic UC. A continuous enhancement effect was observed in mice with acute UC, whereas a slight continuous enhancement of the colorectal wall was observed in mice with chronic UC. The normal intestinal wall rapidly metabolized the contrast agent, and the enhancement decreased on sequential scans. There was no significant difference between the SNRs of the intestinal wall at 20 min after intravenous Gd-DTPA and transrectal Gd-FITC-SLN administration. CONCLUSIONS: Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC and can confer the same or better results than with intravenous Gd-DTPA. KEY POINTS: • Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC. • Enema with Gd-FITC-SLNs can achieve the same or better result than that with intravenous Gd-DTPA. • SLN-based MR colonography enhances the colorectal wall inflammation, based on the colonic absorption of the nanoparticle contrast agents.
format Online
Article
Text
id pubmed-8213572
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82135722021-07-01 Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation Dong, Xue Luo, Jingfeng Lan, Pengxun Guo, Xiuyu Zhao, Xin Wang, Xiaoyan Zhou, Fei Wang, Qiangfeng Yuan, Hong Sun, Jihong Eur Radiol Molecular Imaging OBJECTIVES: To develop a nanoparticle-based MRI protocol based on transrectal administration of intestine-absorbable nanoparticle contrast agents to evaluate ulcerative colitis (UC). METHODS: Solid lipid nanoparticles (SLNs) were synthesized by loading gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) and octadecylamine-fluorescein isothiocyanate to produce Gd-FITC-SLNs as T1 contrast agents. Twenty mice with acute UC were divided into four groups: enema with Gd-FITC-SLNs, intravenous injection of Gd-FITC-SLNs, enema with Gd-DTPA, and intravenous injection of Gd-DTPA. Five mice with chronic UC and five mice without UC underwent enema with Gd-FITC-SLNs. Axial T1- and T2-weighted MR images were obtained before and 20, 40, 60, 80,100, and 120 min after enema or intravenous injection of the contrast agent. The signal-to-noise ratios (SNRs) of the colorectal wall were measured in both groups. The MRI findings were correlated with subsequent histological confirmation. RESULTS: At 20 min after enema with Gd-FITC-SLNs, MRI showed the following contrast enhancement pattern: acute UC > normal intestinal wall > chronic UC. A continuous enhancement effect was observed in mice with acute UC, whereas a slight continuous enhancement of the colorectal wall was observed in mice with chronic UC. The normal intestinal wall rapidly metabolized the contrast agent, and the enhancement decreased on sequential scans. There was no significant difference between the SNRs of the intestinal wall at 20 min after intravenous Gd-DTPA and transrectal Gd-FITC-SLN administration. CONCLUSIONS: Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC and can confer the same or better results than with intravenous Gd-DTPA. KEY POINTS: • Enema with Gd-FITC-SLNs may be helpful for the diagnosis and differential diagnosis of acute and chronic UC. • Enema with Gd-FITC-SLNs can achieve the same or better result than that with intravenous Gd-DTPA. • SLN-based MR colonography enhances the colorectal wall inflammation, based on the colonic absorption of the nanoparticle contrast agents. Springer Berlin Heidelberg 2021-01-06 2021 /pmc/articles/PMC8213572/ /pubmed/33409796 http://dx.doi.org/10.1007/s00330-020-07609-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Molecular Imaging
Dong, Xue
Luo, Jingfeng
Lan, Pengxun
Guo, Xiuyu
Zhao, Xin
Wang, Xiaoyan
Zhou, Fei
Wang, Qiangfeng
Yuan, Hong
Sun, Jihong
Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
title Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
title_full Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
title_fullStr Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
title_full_unstemmed Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
title_short Magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
title_sort magnetic resonance colonography with intestine-absorbable nanoparticle contrast agents in evaluation of colorectal inflammation
topic Molecular Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213572/
https://www.ncbi.nlm.nih.gov/pubmed/33409796
http://dx.doi.org/10.1007/s00330-020-07609-8
work_keys_str_mv AT dongxue magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT luojingfeng magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT lanpengxun magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT guoxiuyu magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT zhaoxin magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT wangxiaoyan magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT zhoufei magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT wangqiangfeng magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT yuanhong magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation
AT sunjihong magneticresonancecolonographywithintestineabsorbablenanoparticlecontrastagentsinevaluationofcolorectalinflammation